Ernest J Mayer

Title: The Innovations of Ernest J Mayer

Introduction

Ernest J Mayer is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of biotechnology, particularly in the development of modified tissue plasminogen activators. With a total of 4 patents to his name, Mayer's work has had a profound impact on medical science.

Latest Patents

Mayer's latest patents include innovative modifications to tissue plasminogen activators. One of his notable inventions is a modified tissue plasminogen activator with a modified glycosylation site. This invention features a t-PA that has an improved in vivo half-life, comprising a fibronectin finger-like domain, a growth factor domain, two K2 kringle regions, and a serine protease region. The first kringle is free of any glycosylation site, while the second has a single glycosylation site. Another significant patent is the modified tissue plasminogen activator K2K2SP, which also boasts an improved in vivo half-life and consists of two K2 kringle regions and a serine protease region.

Career Highlights

Mayer has spent a considerable part of his career at Monsanto Company, where he has been able to apply his expertise in biotechnology. His work has contributed to advancements in medical treatments and therapies, showcasing his commitment to innovation in the field.

Collaborations

Throughout his career, Mayer has collaborated with several talented individuals, including Leslie D Bell and Mark O Palmier. These collaborations have fostered a creative environment that has led to groundbreaking inventions and advancements in biotechnology.

Conclusion

Ernest J Mayer's contributions to the field of biotechnology through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence medical science and improve therapeutic options for patients.